Skip to content
  • About GRP
    • Why Choose Us
    • Leadership
    • Brochure
    • Careers
  • Countries
    • Canada’s Health Canada
    • United States’ FDA
    • Brazil
    • Mexico’s COFEPRIS
    • Europe’s EMA
    • Australia
    • China
    • Japan’s PMDA
    • Korea’s Ministry of Food and Drug Safety (MFDS)
    • Taiwan’s Food and Drug Administration (TFDA)
    • Singapore’s HSA
    • India’s CDSCO

    North America

    Canada

    United States of America

    Latin AMerica

    Brazil

    Mexico

    Europe

    European Union

    Australia

    Australia

    Asia

    China

    Japan

    South Korea

    Taiwan

    Singapore

    India

  • Services

    Medical Devices

    • Authorized Local Agent
    • Regulatory Intelligence
    • Regulatory Strategy
    • Regulatory Affairs
    • Product Registration
    • Medical Writing
    • Health Authority Consultation
    • Clinical

    Pharmaceuticals

    • Authorized Local Agent
    • Regulatory Intelligence
    • Regulatory Strategy
    • Regulatory Affairs
    • Product Registration
    • Regulatory Operations
    • Health Authority Consultation

    Nutraceuticals / Food Supplements

    • Authorized Local Agent
    • Regulatory Intelligence
    • Regulatory Affairs
    • Regulatory Strategy
    • Verification of Nutrient Claims
    • Verification of Health Claims

    Cosmetics & Personal Care Products

    • Authorized Local Agent
    • Regulatory Intelligence
    • Regulatory Affairs
    • Regulatory Strategy
    • Cosmetic Packaging and Labeling Review
    • Product Classification and Formulation Review

    Pharmacovigilance

    • Overview
    • GRP Pharmacoviglance Services

    Quality

    • Preparation for FDA Inspections
    • GMP Mockup Quality Audits
    • ISO 13485 Quality Audits
    • GCP Audits
    • cGTP Audits
    • GAP Analysis Audits
    • Foreign Manufacture Accreditation (FMA)
    • QA SOPs Development
  • Resource Center
    • Blog
    • Market Access Special Programs
    • Press Releases
    • White Papers
    • Case Studies
    • Videos
    • Presentations
    • Brochure
  • RI Platform
    • Japan Regulatory Intelligence (RI)
    • China (NMPA) Regulatory Intelligence
    • Brazil
    • Mexico Regulatory Intelligence (RI)
    • USA Regulatory Intelligence (RI)

    Japan

    • Health Authority
    • Medical Device
    • Pharmaceuticals
    • Clinical Trials
    • Cosmetics
    • Food Supplements

    China

    • Health Authority
    • Medical Device
    • Pharmaceuticals
    • Clinical Trials
    • Cosmetics
    • Food Supplements

    Brazil

    • Health Authority
    • Medical Device
    • Pharmaceuticals
    • Clinical Trials
    • Cosmetics
    • Food Supplements

    Mexico

    • Health Authority
    • Medical Device
    • Pharmaceuticals
    • Clinical Trials
    • Cosmetics
    • Food Supplements

    USA

    • Medical Device
    • Pharmaceuticals
    • Clinical Trials
    • Cosmetics
    • Food Supplements
  • Contact Us
  • About GRP
    • Why Choose Us
    • Leadership
    • Brochure
    • Careers
  • Countries
    • Canada’s Health Canada
    • United States’ FDA
    • Brazil
    • Mexico’s COFEPRIS
    • Europe’s EMA
    • Australia
    • China
    • Japan’s PMDA
    • Korea’s Ministry of Food and Drug Safety (MFDS)
    • Taiwan’s Food and Drug Administration (TFDA)
    • Singapore’s HSA
    • India’s CDSCO
  • Services
  • Resource Center
    • Blog
    • Market Access Special Programs
    • Press Releases
    • White Papers
    • Case Studies
    • Videos
    • Presentations
    • Brochure
  • RI Platform
    • Japan Regulatory Intelligence (RI)
    • China (NMPA) Regulatory Intelligence
    • Brazil
    • Mexico Regulatory Intelligence (RI)
    • USA Regulatory Intelligence (RI)
  • Contact Us
  • About GRP
    • Why Choose Us
    • Leadership
    • Brochure
    • Careers
  • Countries
    • Canada’s Health Canada
    • United States’ FDA
    • Brazil
    • Mexico’s COFEPRIS
    • Europe’s EMA
    • Australia
    • China
    • Japan’s PMDA
    • Korea’s Ministry of Food and Drug Safety (MFDS)
    • Taiwan’s Food and Drug Administration (TFDA)
    • Singapore’s HSA
    • India’s CDSCO
  • Services
  • Resource Center
    • Blog
    • Market Access Special Programs
    • Press Releases
    • White Papers
    • Case Studies
    • Videos
    • Presentations
    • Brochure
  • RI Platform
    • Japan Regulatory Intelligence (RI)
    • China (NMPA) Regulatory Intelligence
    • Brazil
    • Mexico Regulatory Intelligence (RI)
    • USA Regulatory Intelligence (RI)
  • Contact Us
Home / Products / Page 6

Showing 81–96 of 155 results

  • Ministerial Ordinance 179: Good Manufacturing Practices for Drugs

    Ministerial Ordinance 179: Good Manufacturing Practices for Drugs

    $100.00
    Add to cart
  • Ministerial Ordinance No. 36: Good Clinical Practice for Medical Devices

    Ministerial Ordinance No. 36: Good Clinical Practice for Medical Devices

    $30.00
    Add to cart
  • Ministerial Ordinance No.2 Regulations for Facilities of Pharmacies in Japan

    Ministerial Ordinance No.2 Regulations for Facilities of Pharmacies in Japan

    $100.00
    Add to cart
  • Ministerial Ordinance No.21 - Good Laboratory Practice for Nonclinical Safety Studies of Drugs

    Ministerial Ordinance No.21 – Good Laboratory Practice for Nonclinical Safety Studies of Drugs

    $30.00
    Add to cart
  • Ministerial Ordinance on Good Clinical Practice for Drugs

    Ministerial Ordinance on Good Clinical Practice for Drugs

    $30.00
    Add to cart
  • Ministerial Ordinance on Good Laboratory Practice for Nonclinical Safety Studies of Medical Devices

    Ministerial Ordinance on Good Laboratory Practice for Nonclinical Safety Studies of Medical Devices

    $15.00
    Add to cart
  • NMPA Guideline:  Clinical Trial of Orthokeratology Rigid Gas Permeable (RGP) Contact Lenses in China

    NMPA Guideline: Clinical Trial of Orthokeratology Rigid Gas Permeable (RGP) Contact Lenses in China

    $75.00
    Add to cart
  • NMPA Order No.82, 2020: the Issuance of Working Procedures for Review of Breakthrough Therapies in China

    NMPA Order No.82, 2020: the Issuance of Working Procedures for Review of Breakthrough Therapies in China

    $200.00
    Add to cart
  • NMPA Technical Guidelines: Application of Phase I Clinical Trials of New Drugs in China

    NMPA Technical Guidelines: Application of Phase I Clinical Trials of New Drugs in China

    $200.00
    Add to cart
  • NMPA: Guidance for Clinical Evaluation of Proton/Carbon Ion Therapy System

    NMPA: Guidance for Clinical Evaluation of Proton/Carbon Ion Therapy System

    $100.00
    Add to cart
  • NMPA: Guidelines on Registration of Rare Disease Control Medical Devices

    NMPA: Guidelines on Registration of Rare Disease Control Medical Devices

    $150.00
    Add to cart
  • NORMATIVE INSTRUCTION DESCRIBES THE CLASSIFICATION OF RISK OF CADASTRO AND REGISTRO REGISTRATIONS FOR IN VITRO DIAGNOSTIC PRODUCTS

    NORMATIVE INSTRUCTION DESCRIBES THE CLASSIFICATION OF RISK OF CADASTRO AND REGISTRO REGISTRATIONS FOR IN VITRO DIAGNOSTIC PRODUCTS

    $50.00
    Add to cart
  • Sale! Notification 743/1998 : Guideline for Clinical Evaluation of Antibacterial Drugs

    Notification 743/1998 : Guideline for Clinical Evaluation of Antibacterial Drugs

    $15.00 Original price was: $15.00.$14.00Current price is: $14.00.
    Add to cart
  • Notification No. 0620-6  - Study Data for New Drug Applications

    Notification No. 0620-6 – Study Data for New Drug Applications

    $30.00
    Add to cart
  • Operation Specification for Record Filing of Medical Device Master Files

    Operation Specification for Record Filing of Medical Device Master Files

    $150.00
    Add to cart
  • Order No. 15 of the State Food and Drug Administration: Classification Rules for Medical Devices

    Order No. 15 of the State Food and Drug Administration: Classification Rules for Medical Devices

    $200.00
    Add to cart
  • ←
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • →

ABOUT GRP GROUP

  • About US
  • Leadership
  • Why Choose Us

Useful Links

  • Contact Us
  • Brochures
  • Resource Center

GRP Headquarters (USA)

303 Wyman Street, Suite 300
Waltham, MA. 02451, USA
Tel : (+1 ) 781 - 672 -4200
Info@globalregulatorypartners.com

GRP Group Offices

  • GRP USA
  • GRP Japan
  • GRP China
  • GRP Korea
  • GRP Brazil
  • GRP Mexico

Follow Us on Social Media

Twitter Youtube Linkedin
  • Privacy Policy
  • Terms & Conditions
  • Cookies Policy
  • Other Policies

Copyright ©2023 Global Regulatory Partners

Contact Us!